Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 4/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5967194 | 0.96 | SMN1; SMN2 (0.51) | ALDH1A1SMN1; SMN2HTTL3MBTL1ADAMTS4 | |
| SCHEMBL5966841 | 0.96 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2HTTL3MBTL1CTSD | |
| Morpholine SCHEMBL27509052 | 0.91 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2HTTL3MBTL1ADAMTS4 | |
| SCHEMBL6446002 | 0.87 | SMN1; SMN2 (0.49) | ALDH1A1SMN1; SMN2HTTL3MBTL1CYP2D6 | |
| SCHEMBL5967334 | 0.87 | SMN1; SMN2 (0.49) | ALDH1A1SMN1; SMN2HTTL3MBTL1CYP2D6 | |
| SCHEMBL5967098 | 0.87 | SMN1; SMN2 (0.54) | ALDH1A1SMN1; SMN2HTTL3MBTL1ADAMTS4 | |
| SCHEMBL5966897 | 0.86 | SMN1; SMN2 (0.53) | ALDH1A1SMN1; SMN2HTTL3MBTL1ADAMTS4 | |
| SCHEMBL5966981 | 0.85 | SMN1; SMN2 (0.49) | ALDH1A1SMN1; SMN2HTTL3MBTL1CYP2D6 | |
| SCHEMBL7371505 | 0.84 | CCR1 (0.41) | ALDH1A1SMN1; SMN2HTTL3MBTL1KMT2A | |
| SCHEMBL5966978 | 0.83 | POLB (0.52) | ALDH1A1HTTCTSDCYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0942924-A2 | METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 1999-09-22 | — | — | EP | claimed |
| WO-1998022494-A9 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | — | 1998-08-20 | — | — | WO | claimed |
| WO-1998022494-A2 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | claimed |
| EP-0942924-A2 | METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998022494-A9 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | — | 1998-08-20 | — | — | WO | disclosed |
| WO-1998022494-A2 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | disclosed |